From Central Drugs Standard Organisation
Lupin has received approval for Bepotastine Tablets from the Central Drugs Standard Organisation. Lupin shall commence promoting the product in India shortly.Bepotastine is a new second generation antihistamine medicine to be introduced into the Indian Pharmaceutical market which could benefit million of patients suffering from allergic symptoms.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
